Use of oral contraceptives in pregnancy and major structural birth defects in offspring

Epidemiology

Volumn 21, Issue 2, 2010, Pages 232-239

  Waller, Dorothy Kim ^a   Gallaway, Michael Shayne ^a   Taylor, Lockwood G ^a   Ramadhani, Tunu A ^b   Canfield, Mark A ^b   Scheuerle, Angela ^b,c   Hernández Diaz, Sonia ^d,e   Louik, Carol ^d   Correa, Adolfo ^f  

^a UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^b TEXAS DEPARTMENT OF STATE HEALTH SERVICES   (United States)

^c Tesserae Genetics Texas   (United States)

^d BOSTON UNIVERSITY   (United States)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^f NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ADULT; ANENCEPHALUS; ANUS ATRESIA; AORTA COARCTATION; AORTA STENOSIS; ARTICLE; BIRTH DEFECT; CLEFT LIP PALATE; CLEFT PALATE; CONTRACEPTION; CONTROLLED STUDY; CRANIOFACIAL SYNOSTOSIS; DIAPHRAGM HERNIA; ESOPHAGUS ATRESIA; FALLOT TETRALOGY; FEMALE; GASTROSCHISIS; GREAT VESSELS TRANSPOSITION; HEART ATRIUM SEPTUM DEFECT; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEART VENTRICLE SEPTUM DEFECT; HUMAN; HYDROCEPHALUS; HYPOPLASTIC LEFT HEART SYNDROME; HYPOSPADIAS; INTESTINE ATRESIA; KIDNEY AGENESIS; KIDNEY HYPOPLASIA; LIMB REDUCTION DEFECT; LUNG VEIN DRAINAGE ANOMALY; MAJOR CLINICAL STUDY; MICROTIA; NEURAL TUBE DEFECT; NEWBORN; OMPHALOCELE; PREGNANCY; PRIORITY JOURNAL; PULMONARY VALVE ATRESIA; PULMONARY VALVE STENOSIS; SPINA BIFIDA; UNITED STATES; URINARY TRACT MALFORMATION;

ABNORMALITIES, DRUG-INDUCED; ABNORMALITIES, MULTIPLE; ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; CONGENITAL ABNORMALITIES; CONTRACEPTIVES, ORAL; FEMALE; GASTROSCHISIS; HUMANS; HYPOPLASTIC LEFT HEART SYNDROME; ODDS RATIO; PREGNANCY; PREGNANCY TRIMESTER, FIRST; RISK FACTORS; UNITED STATES; URINARY TRACT; YOUNG ADULT;

EID: 77249150530     PISSN: 10443983     EISSN: None     Source Type: Journal    
DOI: 10.1097/EDE.0b013e3181c9fbb3     Document Type: Article

References (41)

1. Hatcher RA, Nelson AL. Combined hormonal contraceptive methods. In: Hatcher RA, Trussell J, Stewart F, et al, eds. Contraceptive Technology. 18th ed. New York: Ardent Median, Inc; 2004;391-460.
2. Kasan PN, Andrews J. Oral contraception and congenital abnormalities. Br J Obstet Gynaecol. 1980;87:545-551.
3. Kricker A, Elliot JW, Forrest JM, McCredie J. Congenital limb reduction deformities and use of oral contraceptives. Am J Obstet Gynecol. 1986;155:1072-1078.
4. Czeizel AE, Kodaj I. A changing pattern in the association of oral contraceptives and the different groups of congenital limb deficiencies. Contraception. 1995;51:19-24.
5. Li DK, Daling JR, Mueller BA, Hickok DE, Fantel AG, Weiss NS. Oral contraceptive use after conception in relation to the risk of congenital urinary tract anomalies. Teratology. 1995;51:30-36.
6. Rothman KJ, Louik C. Oral contraceptives and birth defects. N Engl J Med. 1978;299:522-524.
7. Bracken MB, Holford TR, White C, Kelsey JL. Role of oral contraception in congenital malformations of offspring. Int J Epidemiol. 1978;7: 309-317.
8. Lammer EJ, Cordero JF. Exogenous sex hormone exposure and the risk for major malformations. JAMA. 1986;255:3128-3132.
9. Queisser-Luft A, Eggers I, Stolz G, Kieninger-Baum D, Schlaefer K. Serial examination of 20,248 newborn fetuses and infants: correlations between drug exposure and major malformations. Am J Med Genet. 1996;63:268-276.
10. Martinez-Frias MA, Rodriquez-Pinilla E, Bermejo E, Prieto L. Prenatal exposure to sex hormones: a case-control study. Teratology. 1998;57: 8-12.
11. Bracken MB. Oral contraception and congenital malformations in offspring: a review and meta-analysis of the prospective studies. Obstet Gynecol. 1990;76:552-557.
12. Linn S, Schoenbaum SC, Monson RR, Rosner B, Stubblefield PG, Ryan KJ. Lack of association between contraceptive usage and congenital malformations in offspring. Am J Obstet Gynecol. 1983;147:923-928.
13. Yoon PW, Rasmussen SA, Lynberg MC, et al. The National Birth Defects Prevention Study. Public Health Rep. 2001;116(suppl 1):32-40.
14. Rasmussen SA, Olney RS, Holmes LB, Lin AE, Keppler-Noreuil KM, Moore CA. Guidelines for case classification for the National Birth Defects Prevention Study. Birth Defects Res A Clin Mol Teratol. 2003; 67:193-201.
15. Botto LD, Lin AE, Riehle-Colarusso T, Malik S, Correa A. Seeking causes: classifying and evaluating congenital heart defects in etiologic studies. Birth Defects Res A Clin Mol Teratol. 2007;79:714-727.
16. Dolk H, Vrijheid M, Scott JE, et al. Toward the effective surveillance of hypospadias. Environ Health Perspect. 2004;112:398-402.
17. Jick H, Walker AM, Rothman KJ, et al. Vaginal spermicides and congenital disorders. JAMA. 1981;245:1329-1332.
18. Hoyme UB, Pater TC, Haberlandt WF, Lippert TH. Cooper IUD and congenital malformation? (author's transl) [in German]. Geburtshilfe Frauenheilkd. 1981;41:583-584.
19. Leighton PC, Evans DG, Wallis SM. Letter: IUD and congenital malformation. Br Med J. 1976;1:959-959.
20. Weissmann-Brenner A, Lerner A, Peleg D. Transverse limb reduction and intrauterine device: case report and review of the literature. Eur J Contracept Reprod Health Care. 2007;12:294-297.
21. Barrie H. Congenital malformation associated with intrauterine contraceptive device. Br Med J. 1976;1:488-490.
22. Csecsei K, Szeifert GT, Papp Z. Amniotic bands associated with early rupture of amnion due to an intrauterine device. Zentralbl Gynakol. 1987;109:738-741.
23. Mills JL, Harley EE, Reed GF, Berendes HW. Are spermicides teratogenic? JAMA. 1982;248:2148-2151.
24. Louik C, Mitchell AA, Werler MM, Hanson JW, Shapiro S. Maternal exposure to spermicides in relation to certain birth defects. N Engl J Med. 1987;317:474-478.
25. Strobino B, Kline J, Warburton D. Spermicide use and pregnancy outcome. Am J Public Health. 1988;78:260-263.
26. Bracken MB, Vita K. Frequency of non-hormonal contraception around conception and association with congenital malformations in offspring. Am J Epidemiol. 1983;117:281-291.
27. Tatum HJ, Schmidt FH, Jain AK. Management and outcome of pregnancies associated with the copper T intrauterine contraceptive device. Am J Obstet Gynecol. 1976;126:869-879.
28. Layde PM, Goldberg MF, Safra MJ, Oakley GP. Failed intrauterine device contraception and limb reduction deformities: a case-control study. Fertil Steril. 1979;31:18-20.
29. Burton GJ, Watson AL, Hempstock J, Skepper JN, Jauniaux E. Uterine glands provide histiotrophic nutrition for the human fetus during the first trimester of pregnancy. J Clin Endocrinol Metab. 2002;87:2954-2959.
30. Werler MM, Mitchell AA, Shapiro S. First trimester maternal medication use in relation to gastroschisis. Teratology. 1992;45:361-367.
31. Torfs CP, Katz EA, Bateson TF, Lam PK, Curry CJ. Maternal medications and environmental exposures as risk factors for gastroschisis. Teratology. 1996;54:84-92.
32. Sweet RA, Schrott HG, Kurland R, Culp OS. Study of the incidence of hypospadias in Rochester, Minnesota, 1940-1970, and a case-control comparison of possible etiologic factors. Mayo Clin Proc. 1974;49:52-58.
33. Calzolari E, Contiero MR, Roncarati E, Mattiuz PL, Volpato S. Aetiological factors in hypospadias. J Med Genet. 1986;23:333-337.
34. Polednak AP, Janerich DT. Maternal characteristics and hypospadias: a case-control study. Teratology. 1983;28:67-73.
35. Czeizel A, Tóth J. Correlation between the birth prevalence of isolated hypospadias and parental subfertility. Teratology. 1990;41:167-172.
36. Källén B, Castilla EE, Kringelbach M, et al. Parental fertility and infant hypospadias: an international case-control study. Teratology. 1991;44: 629-634.
37. Raman-Wilms L, Tseng AL, Wighardt S, Einarson TR, Koren G. Fetal genital effects of first-trimester sex hormone exposure: a meta-analysis. Obstet Gynecol. 1995;85:141-149.
38. Carmichael SL, Shaw GM, Laurent C, Croughan MS, Olney RS, Lammer EJ. Maternal progestin intake and risk of hypospadias. Arch Pediatr Adolesc Med. 2005;159:957-962.
39. Källén B, Mastroiacovo P, Lancaster PA, et al. Oral contraceptives in the etiology of isolated hypospadias. Contraception. 1991;44:173-182.
40. Perone N. The progestins. In: Goldzieher JW, Fotherby K, eds. Phar-mocology of the Contraceptive Steroids. New York: Raven Press; 1994:5-25.
41. Zhu JL, Basso O, Obel C, Bille C, Olsen J. Infertility, infertility treatment, and congenital malformations: Danish national birth cohort. BMJ. 2006;333:679.